Psychiatrists Dismiss Patient Evidence Against ECT as “Anecdotal” to Protect Profits

In 2015, the U.S. Food and Drug Administration issued its “Neurological Devices; Reclassification of Electroconvulsive Therapy Devices Intended for Use in Treating,” recommending that the ECT device be rated Class II (less risk classification than its current Class III) for: Severe major depressive episode (MDE) associated with major depressive disorder (MDD) or bipolar disorder (BPD) … Read more Psychiatrists Dismiss Patient Evidence Against ECT as “Anecdotal” to Protect Profits

Conflicts of Interest Regarding ECT Covers Up Damage

Excerpted from CCHR’s submission to the FDA opposing its 2015 proposal to reclassify the ECT device as a Class II low risk device. CCHR’s submission was submitted in March 2016. The Food and Drug Administration (FDA) Proposal in 2015 to reduce the risk classification of the ECT device instead of banning it, is of enormous … Read more Conflicts of Interest Regarding ECT Covers Up Damage

Electroshock: Lawsuits and Death Findings

The long-term damaging effects of ECT has led to wrongful death lawsuits, as well as other grounds for law suits, including assault and battery and ECT causing personal injury, including brain damage and memory loss. The following is an example of coroner inquest findings and lawsuits, indicting the increasing recourse electroshock patients or their families … Read more Electroshock: Lawsuits and Death Findings